Methods During May and June of 2006, we reviewed the prescribing information for medications labeled for refrigeration as obtained from the supplier for data addressing room-temperature storage ...

The Zomedica R&D team was also able to increase the already industry-leading dynamic range of the standard (or default, undiluted) in-clinic insulin test by 60%! The chart below illustrates the new ...

Two commercially available regular insulin preparations include Humulin R, manufactured by Lilly, and Novolin R, manufactured by Novo Nordisk.

NPH is administered with an insulin pen or syringe to the stomach, thighs, or upper arms. Humulin N is one brand of NPH insulin produced by Eli Lilly and Company, and Novo Nordisk makes Novolin N.

Ellison says the settlement requires Novo Nordisk to provide insulin products—including Novolog, Tresiba, Fiasp, and Novolin, at any formulation and via any delivery method—at $35 per monthly ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over ...

Vietnam veteran John Kriel usually gets his Novolin 70/30 FlexPen insulin to manage his Type 2 diabetes from the Milwaukee Veterans Affairs Hospital, but his wife said this month's supply never came.

Minnesota attorney general Keith Ellison is steadily stacking up settlement deals with top insulin makers, this time pushing Sanofi to provide its insulin to Minnesotans for a monthly price of $35.

Scientists have tested a new drug therapy in diabetic mice, and found that it boosted insulin-producing cells by 700% over three months, effectively reversing their disease.

Basal insulin is longer-acting and helps keep your glucose levels steady day and night. Generally, your total daily dosage of injected insulin is split between these short- and longer-acting kinds.

"We trust that when we are given medication, that it's correct:" A Mocksville woman has filed a complaint with the North Carolina Board Of Pharmacy after she says she was given the wrong insulin.

Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria.